Geroprotective and Anticarcinogenic Activity Lifetime Murine Studies Long-term studies in mice demonstrated that DSIP administration over a lifetime decreased total spontaneous tumour incidence 2.6-fold compared to untreated controls, slowed age-related switching-off of oestrous function, decreased the frequency of chromosome aberrations in bone marrow cells by 22.6%, and increased maximum lifespan by 24.1% compared to control groups a multi-parameter geroprotective profile that is among the most striking reported for any short regulatory peptide, and that has generated sustained interest in the DSIP analogue research field
Cell Dev Biol 2020;8 592433
Between wellness culture, beach lifestyles, and year-round sunshine (hello, UV exposure), looking fresh and feeling confident is practically a local sport
Research Use Only Notice: This product is sold for laboratory research purposes only
Not sure what your triggers are
At AlphaMD, we understand that beginning testosterone therapy can bring up many questions, one of the most common being, "Where should I inject testosterone
